These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24434372)

  • 21. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate.
    Valotis A; Högger P
    Respir Res; 2007 Jul; 8(1):54. PubMed ID: 17650349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids.
    Galuppo M; Rossi A; Giacoppo S; Pace S; Bramanti P; Sautebin L; Mazzon E
    Pharmacol Res; 2015 Sep; 99():316-28. PubMed ID: 26192346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of fluticasone on extracellular matrix production by airway and parenchymal fibroblasts in severe COPD.
    Brandsma CA; Timens W; Jonker MR; Rutgers B; Noordhoek JA; Postma DS
    Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L582-9. PubMed ID: 23997174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of three nasal topical steroids in the intraocular pressure compartment.
    Bross-Soriano D; Hanenberg-Milver C; Schimelmitz-Idi J; Arrieta-Gomez JR; Astorga del Toro R; Bravo-Escobar G
    Otolaryngol Head Neck Surg; 2004 Feb; 130(2):187-91. PubMed ID: 14990914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.
    Maspero J; Cherrez I; Doherty DE; Tashkin DP; Kuna P; Kuo WL; Gates D; Nolte H; Chylack LT
    Respir Med; 2014 Sep; 108(9):1355-62. PubMed ID: 25044280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells.
    Mullol J; de Borja Callejas F; Martínez-Antón MA; Méndez-Arancibia E; Alobid I; Pujols L; Valero A; Picado C; Roca-Ferrer J
    Respir Res; 2011 Feb; 12(1):23. PubMed ID: 21352574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluticasone propionate and mometasone furoate have a low risk of contact sensitization.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):365-6. PubMed ID: 8807234
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation.
    Choi WH; Ji KA; Jeon SB; Yang MS; Kim H; Min KJ; Shong M; Jou I; Joe EH
    Biochem Biophys Res Commun; 2005 Apr; 329(1):125-31. PubMed ID: 15721283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
    Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
    Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
    Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
    Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.
    Sands WA; Woolson HD; Milne GR; Rutherford C; Palmer TM
    Mol Cell Biol; 2006 Sep; 26(17):6333-46. PubMed ID: 16914720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the use of fluticasone furoate since its launch.
    Villa E; Magnoni MS; Micheli D; Canonica GW
    Expert Opin Pharmacother; 2011 Sep; 12(13):2107-17. PubMed ID: 21797803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle.
    Oltmanns U; Walters M; Sukkar M; Xie S; Issa R; Mitchell J; Johnson M; Chung KF
    Pulm Pharmacol Ther; 2008; 21(2):292-7. PubMed ID: 17692547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
    Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
    Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR‑409‑3p suppresses LPS‑induced inflammation in human bronchial epithelial cells through SOCS3/JAK1/STAT3 signaling: The implication for bronchopneumonia.
    He L; Tian L
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease.
    Matera MG; Capuano A; Cazzola M
    Expert Rev Respir Med; 2015 Feb; 9(1):5-12. PubMed ID: 25482512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologically-induced mitotic synchrony in airway epithelial cells as a mechanism of action of anti-inflammatory drugs.
    Freishtat RJ; Nino G; Tsegaye Y; Alcala SE; Benton AS; Watson AM; Reeves EK; Haider SK; Damsker JM
    Respir Res; 2015 Oct; 16():132. PubMed ID: 26511361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.